Browse by author
Lookup NU author(s): Dr Fiona Smith, Dr Philip Langley, Emeritus Professor Alan MurrayORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Recent guideline drafts of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) underline the necessity to test nonantiarrhythmic drugs for their potential to prolong the QT or the corrected QT (QTc) interval. The implementation of these guidelines requires a large amount of ECG measurements on animals and humans in preclinical and clinical phases of the drug development process. We propose the use of magnetocardiography (MCG) as a complementary method with particular advantages in high-throughput studies, where signal quality and reliability are key factors. Our proposal is based on a review of recent MCG studies investigating the repolarization phase and results of methodological work assessing QT interval parameters from the MCG. The applicability of MCG for pre-clinical in-vivo studies is demonstrated by the ease of measurement in unrestrained non-anesthetized rabbits, guinea pigs, and hamsters..
Author(s): Steinhoff U, Knappe-Grueneberg S, Schnabel A, Trahms L, Smith F, Langley P, Murray A, Koch H
Publication type: Article
Publication status: Published
Journal: Journal of Electrocardiology
Year: 2004
Volume: 37
Pages: 187-192
Print publication date: 01/01/2004
ISSN (print): 0022-0736
ISSN (electronic): 1532-8430
Publisher: Churchill Livingstone
URL: http://dx.doi.org/10.1016/j.jelectrocard.2004.08.055
DOI: 10.1016/j.jelectrocard.2004.08.055
Altmetrics provided by Altmetric
